Further Information
SETDB2, CLLD8, SET domain, bifurcated 2, CLLL8 protein, C13orf4, CLLL8, DKFZp586I0123, DKFZp761J1217, KMT1F, chronic lymphocytic leukemia deletion region 8, lysine N-methyltransferase 1F, histone-lysine N-methyltransferase SETDB2
Peptide ELISA: antibody detection limit dilution 1:8000.Western Blot:Approx 80kDa band observed in Human Heart lysates (calculated MW of 81.9kDa according to NP_114121.1). Recommended concentration: 1.5-4.5ug/ml.
This product is not suitable in WB on Mouse Heart and Rat Heart lysates.
- Mabuchi H, Fujii H, Calin G, Alder H, Negrini M, Rassenti L, Kipps TJ, Bullrich F, Croce CM. Cloning and characterization of CLLD6, CLLD7, and CLLD8, novel candidate genes for leukemogenesis at chromosome 13q14, a region commonly deleted in B-cell chronic lymphocytic leukemia. Cancer Res. 2001 Apr 1;61(7):2870-7.
Supplied at 0.5 mg/ml in Tris saline, 0.02% sodium azide, pH7.3 with 0.5% bovine serum albumin.
Aliquot and store at -20?C. Minimize freezing and thawing.
500 ug/mL
Unconjugated
Optimal dilutions/concentrations should be determined by the end user. The information provided is a guideline for product use. Optimal dilutions/concentrations should be determined by the end user. The information provided is a guideline for product use. This product is for research use only.
Expected Species Reactivity based on sequence homology: Mouse, Rat, Dog, Pig, Cow
The immunogen for this antibody is: GEKNGDAKTFWME-C
83852
SET domain, bifurcated 2
SETDB2
Homo sapiens
Liquid
NP_114121.2, NP_001153780.1
13994282
Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide.
Cancer
This antibody is expected to recognize both reported isoforms (NP_114121.2; NP_001153780.1).
Q96T68